Efficacy, Safety, and Tolerability of Gepotidacin (GSK2140944) in the Treatment of Patients with Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections

Gepotidacin is a novel, first-in-class, triazaacenaphthylene antibacterial agent which has in vitro activity against causative pathogens of acute bacterial skin and skin structure infections (ABSSSIs). This phase 2, randomized, 2-part, multicenter, dose-ranging, response-adaptive study with optional...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Riordan, William, Tiffany, Courtney, Scangarella-Oman, Nicole, Perry, Caroline, Hossain, Mohammad, Ashton, Teri, Dumont, Etienne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2017
Materias:
Clinical Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444153/
https://www.ncbi.nlm.nih.gov/pubmed/28373199
http://dx.doi.org/10.1128/AAC.02095-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444153/
https://www.ncbi.nlm.nih.gov/pubmed/28373199
http://dx.doi.org/10.1128/AAC.02095-16

Ejemplares similares